102 related articles for article (PubMed ID: 27539058)
21. In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase.
Chung-Faye GA; Chen MJ; Green NK; Burton A; Anderson D; Mautner V; Searle PF; Kerr DJ
Gene Ther; 2001 Oct; 8(20):1547-54. PubMed ID: 11704815
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic strategies for locally recurrent and metastatic de-differentiated liposarcoma with herpes simplex virus-thymidine kinase-expressing mesenchymal stromal cells.
Lee H; Jo EB; Kim SJ; Yang HM; Kim YM; Sung YC; Park JB; Hong D; Park H; Choi YL; Kim SJ
Cytotherapy; 2017 Sep; 19(9):1035-1047. PubMed ID: 28760351
[TBL] [Abstract][Full Text] [Related]
23. Targeted inhibition of osteosarcoma tumor growth by bone marrow-derived mesenchymal stem cells expressing cytosine deaminase/5-fluorocytosine in tumor-bearing mice.
NguyenThai QA; Sharma N; Luong do H; Sodhi SS; Kim JH; Kim N; Oh SJ; Jeong DK
J Gene Med; 2015; 17(3-5):87-99. PubMed ID: 25808408
[TBL] [Abstract][Full Text] [Related]
24. Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase.
Hartkopf AD; Bossow S; Lampe J; Zimmermann M; Taran FA; Wallwiener D; Fehm T; Bitzer M; Lauer UM
Gynecol Oncol; 2013 Aug; 130(2):362-8. PubMed ID: 23676551
[TBL] [Abstract][Full Text] [Related]
25. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line.
Trinh QT; Austin EA; Murray DM; Knick VC; Huber BE
Cancer Res; 1995 Nov; 55(21):4808-12. PubMed ID: 7585511
[TBL] [Abstract][Full Text] [Related]
26. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer.
Rancourt C; Bergeron C; Lane D; Garon G; Piché A
Cytotherapy; 2003; 5(6):509-22. PubMed ID: 14660047
[TBL] [Abstract][Full Text] [Related]
27. 3D multicellular models reflect the efficiency of MSC-directed enzyme/prodrug treatment.
Bohovic R; Demkova L; Cihova M; Skolekova S; Durinikova E; Toro L; Tyciakova S; Kozovska Z; Matuskova M; Kucerova L
Neoplasma; 2015; 62(4):521-30. PubMed ID: 25997965
[TBL] [Abstract][Full Text] [Related]
28. Mesenchymal stem cells expressing therapeutic genes induce autochthonous prostate tumour regression.
Abrate A; Buono R; Canu T; Esposito A; Del Maschio A; Lucianò R; Bettiga A; Colciago G; Guazzoni G; Benigni F; Hedlund P; Altaner C; Montorsi F; Cavarretta IT
Eur J Cancer; 2014 Sep; 50(14):2478-88. PubMed ID: 25060826
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/ 5-fluorocytosine suicide gene therapy-induced cell death in glioma cells.
Fischer U; Steffens S; Frank S; Rainov NG; Schulze-Osthoff K; Kramm CM
Oncogene; 2005 Feb; 24(7):1231-43. PubMed ID: 15592511
[TBL] [Abstract][Full Text] [Related]
30. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
[TBL] [Abstract][Full Text] [Related]
31. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
[TBL] [Abstract][Full Text] [Related]
32. Expression of Escherichia coli uracil phosphoribosyltransferase gene in murine colon carcinoma cells augments the antitumoral effect of 5-fluorouracil and induces protective immunity.
Kawamura K; Tasaki K; Hamada H; Takenaga K; Sakiyama S; Tagawa M
Cancer Gene Ther; 2000 Apr; 7(4):637-43. PubMed ID: 10811483
[TBL] [Abstract][Full Text] [Related]
33. Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity.
Kaliberov SA; Chiz S; Kaliberova LN; Krendelchtchikova V; Della Manna D; Zhou T; Buchsbaum DJ
Cancer Gene Ther; 2006 Feb; 13(2):203-14. PubMed ID: 16082379
[TBL] [Abstract][Full Text] [Related]
34. HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells.
Matuskova M; Hlubinova K; Pastorakova A; Hunakova L; Altanerova V; Altaner C; Kucerova L
Cancer Lett; 2010 Apr; 290(1):58-67. PubMed ID: 19765892
[TBL] [Abstract][Full Text] [Related]
35. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes.
Jacobs AH; Winkeler A; Hartung M; Slack M; Dittmar C; Kummer C; Knoess C; Galldiks N; Vollmar S; Wienhard K; Heiss WD
Hum Gene Ther; 2003 Feb; 14(3):277-97. PubMed ID: 12639307
[TBL] [Abstract][Full Text] [Related]
36. Genetically engineered mesenchymal stromal cells producing TNFα have tumour suppressing effect on human melanoma xenograft.
Tyciakova S; Matuskova M; Bohovic R; Polakova K; Toro L; Skolekova S; Kucerova L
J Gene Med; 2015; 17(1-2):54-67. PubMed ID: 25677845
[TBL] [Abstract][Full Text] [Related]
37. A novel mechanism of synergistic cytotoxicity with 5-fluorocytosine and ganciclovir in double suicide gene therapy.
Boucher PD; Im MM; Freytag SO; Shewach DS
Cancer Res; 2006 Mar; 66(6):3230-7. PubMed ID: 16540675
[TBL] [Abstract][Full Text] [Related]
38. Complete regression of metastatic renal cell carcinoma by multiple injections of engineered mesenchymal stem cells expressing dodecameric TRAIL and HSV-TK.
Kim SW; Kim SJ; Park SH; Yang HG; Kang MC; Choi YW; Kim SM; Jeun SS; Sung YC
Clin Cancer Res; 2013 Jan; 19(2):415-27. PubMed ID: 23204131
[TBL] [Abstract][Full Text] [Related]
39. Cytosine deaminase versus thymidine kinase: a comparison of the antitumor activity.
Corban-Wilhelm H; Becker G; Bauder-Wüst U; Greulich D; Debus J
Clin Exp Med; 2003 Nov; 3(3):150-6. PubMed ID: 14648229
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.
Xie Y; Gilbert JD; Kim JH; Freytag SO
Clin Cancer Res; 1999 Dec; 5(12):4224-32. PubMed ID: 10632364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]